China Biotech Innovation ETF (CHB)

NASDAQ: CHB · IEX Real-Time Price · USD
12.04
-0.36 (-2.90%)
Jan 26, 2022 3:31 PM EST - Market closed
Assets$3.26M
NAV$12.07
Expense Ratio0.67%
PE Ratio77.34
Shares Out270,000
Dividend (ttm)0.15
Dividend Yield0.95%
Ex-Dividend Daten/a
1-Year Return-30.36%
Volume1,098
Open11.94
Previous Close12.40
Day's Range12.04 - 12.28
52-Week Low11.71
52-Week High11.71
Beta-0.20
Holdings36
Inception DateSep 22, 2020

About CHB

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index (underlying index). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China's biotechnology industry. It is non-diversified.

Asset ClassEquity
RegionAsia-Pacific
IssuerGlobal X Mgt
Stock ExchangeNASDAQ
Ticker SymbolCHB
Index TrackedSolactive China Biotech Innovation Index

Top 10 Holdings

59.13% of assets
NameSymbolWeight
WALVAX BIOTECHNOLOGY CO-AN/A9.13%
SHENZHEN KANGT-AN/A7.65%
WUXI BIOLOGICS CAYMAN INC2269.HK7.12%
CHANGCHUN HIGH-AN/A6.64%
BeiGeneBGNE6.46%
SINO BIOPHARMACEUTICAL1177.HK5.69%
HUALAN BIOLOGI-AN/A4.92%
GENSCRIPT BIOTECH CORP1548.HK4.53%
SHANGHAI RAAS -AN/A3.71%
FU JIAN ANJOY-AN/A3.28%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Jan 25, 2022$NaNJan 31, 2022
Dec 30, 2021$NaNJan 6, 2022
Jun 29, 2021$NaNJul 8, 2021
Full Dividend History

News

5 Top-Performing ETFs of Last Week

Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.

Other symbols:CHIHEPUKURE
8 months ago - Zacks Investment Research

The CHB ETF: China's Burgeoning Biotech Sector

As China continues to lead the global recovery, one area to keep a close eye on is biotechnology and the Global X China Biotech Innovation ETF (CHB). CHB seeks to provide investment results that corresp...

8 months ago - ETF Trends

Are Healthcare ETFs Poised for a Comeback?

Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.

9 months ago - Zacks Investment Research

ETF Odds & Ends: First Mutual Fund Conversion

Plus, iShares lowered expense ratios on two of its ETFs.

9 months ago - ETFcom

3 Biotech Stocks With Eye-Catching Pipelines

Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorP...

Other symbols:ABBVRPRX
1 year ago - InvestorPlace

China's Quest for a Covid-19 Vaccine Could Help Boost This ETF

All around the world, economic superpowers are vying to be the first to develop a vaccine for Covid-19. China is an obvious contender given that the country was the epicenter of the virus and their succ...

1 year ago - ETF Trends